Theralase achieves breakthrough Herpes treatment
Clinical-stage pharma stock Theralase Technologies (TSXV:TLT) announced a significant breakthrough in the treatment of Herpes ...
PharmiWeb3 小时
Theralase(R) Releases Latest Research on Inactivation of Herpes Simplex Viruses
University of Manitoba independent research verifies that RuvidarTM is more effective than acyclovir in the inactivation of Herpes Simplex Viruses post infection. TORONTO, ON / ACCESS Newswire / ...
Theralase Technologies, Inc.: Theralase Releases Latest Research on Inactivation of Herpes ...
University of Manitoba independent research verifies that RuvidarTM is more effective than acyclovir in the inactivation of Herpes Simplex Viruses post infection. TORONTO, ON / ACCESS Newswire / Febru ...